Insiders Lumos Pharma, Inc.

Equities

LUMO

US55028X1090

Market Closed - Nasdaq Other stock markets 02:00:00 11/05/2024 am IST			5-day change	1st Jan Change
2.9 ^USD	-3.97%		-2.03%	-8.81%

07/03	Lumos Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
07/03	Transcript : Lumos Pharma, Inc., 2023 Earnings Call, Mar 07, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lumos Pharma, Inc. Promotes Pisit Pitukcheewanont to Chief Medical Officer	05/01	CI
Lumos Pharma Says Chief Medical Officer Leaving; Shares Drop	29/23/29	MT
Lumos Pharma, Inc. Announces Departure of David B. Karpf, Chief Medical Officer, Effective June 29, 2023	29/23/29	CI
Insider Buy: Lumos Pharma	11/21/11	MT
Insider Buy: Lumos Pharma	08/21/08	MT
Lumos Pharma Appoints David B. Karpf as Chief Medical Officer	03/21/03	CI
Lumos Pharma, Inc. Announces Executive Changes	02/21/02	CI
Lumos Pharma, Inc. Appoints Mark Bach to the Company’s Clinical Scientific Advisory Board	27/21/27	CI
Lumos Pharma, Inc. Appoints Eddie L. Varnado as Corporate Controller	21/21/21	CI
Lumos Pharma, Inc. Announces Board Changes	17/21/17	CI
Lumos Pharma, Inc. Announces Resignation of Eugene P. Kennedy as Chief Medical Officer, Effective March 6, 2021	09/21/09	CI
Insider Trends: Selling By Insiders Continues at Lumos Pharma	09/21/09	MT
Lumos Pharma Hires Aaron Schuchart as Chief Business Officer, Effective May 6, 2020	24/20/24	CI
Lumos Pharma, Inc. Promotes John C. Mckew to Chief Operating Officer and Chief Scientific Officer	03/20/03	CI
Lumos Pharma, Inc. Announces Executive Changes	28/20/28	CI
NewLink Genetics Corporation Announces Executive Changes	19/20/19	CI
Lumos Pharma, Inc. Announces New Board of Directors	18/20/18	CI
NewLink Genetics Corporation has Changed its Name to Lumos Pharma, Inc	18/20/18	CI
Newlink Genetics Corporation Announces Retirement of Nicholas Vahani as President and from Its Board of Directors; to Reduce Its Workforce by 28 Employees (Approximately 60%)	01/19/01	CI
Newlink Genetics Corporation Announces Executive Changes	30/19/30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Lumos Pharma, Inc.

Equities

LUMO

US55028X1090

Insiders

Filters